CSL Limited CSLLY Stock
CSL Limited Price Chart
CSL Limited CSLLY Financial and Trading Overview
| CSL Limited stock price | 20.06 USD |
| Previous Close | 19.91 USD |
| Open | 19.81 USD |
| Bid | 19.99 USD x 10000 |
| Ask | 20.03 USD x 314900 |
| Day's Range | 19.81 - 20.03 USD |
| 52 Week Range | 16.01 - 44.86 USD |
| Volume | 30.86K USD |
| Avg. Volume | 505.97K USD |
| Market Cap | 38.27B USD |
| Beta (5Y Monthly) | 0.094 |
| PE Ratio (TTM) | 12.974026 |
| EPS (TTM) | 1.54 USD |
| Forward Dividend & Yield | 0.72 (3.61%) |
| Ex-Dividend Date | March 11, 2026 |
| 1y Target Est | 25.54 USD |
CSLLY Valuation Measures
| Enterprise Value | 50.33B USD |
| Trailing P/E | 12.974026 |
| Forward P/E | 12.703217 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4842372 |
| Price/Book (mrq) | 2.0651696 |
| Enterprise Value/Revenue | 3.266 |
| Enterprise Value/EBITDA | 10.398 |
Trading Information
CSL Limited Stock Price History
| Beta (5Y Monthly) | 0.094 |
| 52-Week Change | -49.54% |
| S&P500 52-Week Change | 18.51% |
| 52 Week High | 44.86 USD |
| 52 Week Low | 16.01 USD |
| 50-Day Moving Average | 19.75 USD |
| 200-Day Moving Average | 27 USD |
CSLLY Share Statistics
| Avg. Volume (3 month) | 505.97K USD |
| Avg. Daily Volume (10-Days) | 577.56K USD |
| Shares Outstanding | 1.92B |
| Float | 1.93B |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.0089% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.92 |
| Trailing Annual Dividend Yield | 14.66% |
| 5 Year Average Dividend Yield | 151.00% |
| Payout Ratio | 0.4457 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 9.06% |
| Operating Margin (ttm) | 31.64% |
| Gross Margin | 51.87% |
| EBITDA Margin | 31.41% |
Management Effectiveness
| Return on Assets (ttm) | 6.57% |
| Return on Equity (ttm) | 6.66% |
Income Statement
| Revenue (ttm) | 15.41B USD |
| Revenue Per Share (ttm) | 7.96 USD |
| Quarterly Revenue Growth (yoy) | -1.79% |
| Gross Profit (ttm) | 7.99B USD |
| EBITDA | 4.84B USD |
| Net Income Avi to Common (ttm) | 1.4B USD |
| Diluted EPS (ttm) | 1.54 |
| Quarterly Earnings Growth (yoy) | -80.00000000000000000000000000000000% |
Balance Sheet
| Total Cash (mrq) | 1.14B USD |
| Total Cash Per Share (mrq) | 0.59 USD |
| Total Debt (mrq) | 11.14B USD |
| Total Debt/Equity (mrq) | 54.44 USD |
| Current Ratio (mrq) | 2.571 |
| Book Value Per Share (mrq) | 9.67475 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.6B USD |
| Levered Free Cash Flow (ttm) | 1.85B USD |
Profile of CSL Limited
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | 655 Elizabeth Street |
| ZIP | 3000 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29904 |
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Q&A For CSL Limited Stock
What is a current CSLLY stock price?
CSL Limited CSLLY stock price today per share is 20.06 USD.
How to purchase CSL Limited stock?
You can buy CSLLY shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL Limited?
The stock symbol or ticker of CSL Limited is CSLLY.
Which industry does the CSL Limited company belong to?
The CSL Limited industry is Biotechnology.
How many shares does CSL Limited have in circulation?
The max supply of CSL Limited shares is 1.92B.
What is CSL Limited Price to Earnings Ratio (PE Ratio)?
CSL Limited PE Ratio is 13.02597400 now.
What was CSL Limited earnings per share over the trailing 12 months (TTM)?
CSL Limited EPS is 1.54 USD over the trailing 12 months.
Which sector does the CSL Limited company belong to?
The CSL Limited sector is Healthcare.